These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6218072)

  • 1. Presence of host-reactive T cells in lymphohaematopoietic chimeras.
    Waterfield JD; King ID; Dutton RW
    Immunology; 1983 Feb; 48(2):219-27. PubMed ID: 6218072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras: functional restriction to host MHC.
    Colson YL; Tripp RA; Doherty PC; Wren SM; Neipp M; Abou El-Ezz AY; Ildstad ST
    J Immunol; 1998 Apr; 160(8):3790-6. PubMed ID: 9558082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic radiation chimeras respond to TNP-modified donor and host targets.
    Lattime EC; Gershon HE; Stutman O
    J Immunol; 1980 Jan; 124(1):274-8. PubMed ID: 6444228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-viral immune response of allogeneic irradiation bone marrow chimeras: cytotoxic T cell responsiveness depends upon H-2 combination and infectious agent.
    Zinkernagel RM; Sado T; Althage A; Kamisaku H
    Eur J Immunol; 1984 Jan; 14(1):14-23. PubMed ID: 6198181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Specificity of cell-mediated cytotoxicity. II. Cytotoxic lymphocytes after in vitro allogeneic sensitization in the H-2 system].
    Schulze HA; Brock J
    Allerg Immunol (Leipz); 1983; 29(2):100-7. PubMed ID: 6224410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    Bonavida B; Katz J
    J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of the T cell repertoire during ontogeny: limiting dilution analysis.
    Teh HS; Bennink J; Von Boehmer H
    Eur J Immunol; 1982 Oct; 12(10):887-92. PubMed ID: 6983444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and stimulator cell requirements for generation and activation of minor histocompatibility antigen-specific memory cytotoxic T-lymphocyte precursors.
    Ando KI; Isobe KI; Hasegawa T; Iwamoto T; Ding RN; Rahman J; Muro Y; Yoshida T; Nagase F; Kawashima K
    Immunology; 1988 Aug; 64(4):661-7. PubMed ID: 2971608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of interleukin 2-producing T helper cells within murine Lyt-2+ T lymphocytes: frequency, specificity and clonal segregation from Lyt-2+ precursors of cytotoxic T lymphocytes.
    Heeg K; Steeg C; Hardt C; Wagner H
    Eur J Immunol; 1987 Feb; 17(2):229-36. PubMed ID: 2951263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral tolerance mechanisms prevent the development of autoreactive T cells in chimeras grafted with two minor incompatible thymuses.
    Zamoyska R; Waldmann H; Matzinger P
    Eur J Immunol; 1989 Jan; 19(1):111-7. PubMed ID: 2522046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses of thymus/lymphocyte embryonic chimeras: studies on tolerance and major histocompatibility complex restriction in Xenopus.
    Flajnik MF; Du Pasquier L; Cohen N
    Eur J Immunol; 1985 Jun; 15(6):540-7. PubMed ID: 3874068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of MHC-linked, T cell-mediated suppression is regulated by the T cell genotype.
    Araneo BA
    J Mol Cell Immunol; 1986; 2(4):219-31. PubMed ID: 2855403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras.
    Onoé K; Gotohda T; Nishihori H; Aranami T; Iwabuchi C; Iclozan C; Morohashi T; Ogasawara K; Good RA; Iwabuchi K
    Transpl Immunol; 2003; 12(1):79-88. PubMed ID: 14551035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.
    Brochu S; Baron C; Hétu F; Roy DC; Perreault C
    J Immunol; 1995 Dec; 155(11):5104-14. PubMed ID: 7594519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the major histocompatibility complex in targeting effector T cells into a site of virus infection.
    Doherty PC; Allan JE
    Eur J Immunol; 1986 Oct; 16(10):1237-42. PubMed ID: 3490385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.